japanese encephalitis virus vaccine, suspension of infected mouse brain
Vaccineapproved
Approved
Jul 10, 1945
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jan 1, 2008 (NCT01386827)
Timeline
1940s
- Jul 10, 1945
Earliest FDA Approval
2000s
- Jan 1, 2008
Earliest Phase 3 Sponsor(trial)
Indications
Approved for
Studied for
Mechanism of action
- Japanese encephalitis virusImmunity, active
Japanese encephalitis virus immunity, active
Approval history
- approvedJul 10, 1945
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- japanese encephalitis virus vaccine, suspension of infected mouse brain
- mouse brain derived japanese encephalitis vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01386827 | Phase 3 | Jan 1, 2008 | Karolinska Institute, Swedish Institute for Infectious Disease Control, University of Helsinki |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Karolinska Institute | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Swedish Institute for Infectious Disease Control | Government | 1 | 0 | 1 | 2008 |
| University of Helsinki | Academic/Hospital | 1 | 1 | 1 | 2008 |
3 organizations
Page 1 / 1